Anna Pare, MD
Dermatology · Atlanta, GANPI 1437135274
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Galderma Laboratories, L.p. at 45.6% of the total. Among dermatology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 596 payments — averaging $97.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$26K
- AbbVie$15K
- Aclaris Therapeutics, Inc.$6K
- Merz North America, Inc.$3K
- Sanofi$2K
- Revance Therapeutics, Inc.$1K
- plus $5K from 26 others
What the payments were for
- Consulting fees$12,40021%
- Speaking & faculty fees$22,90240%
- Travel & lodging$8,03614%
- Food & beverage$14,39225%
- Education$860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 84 | $26,381 |
| AbbVie(2 entities) | 168 | $15,232 |
| Aclaris Therapeutics, Inc. | 21 | $5,620 |
| Merz North America, Inc. | 18 | $2,688 |
| Sanofi | 47 | $1,966 |
| Revance Therapeutics, Inc. | 32 | $1,292 |
| Incyte Corporation | 35 | $780 |
| Novartis | 38 | $708 |
| Regeneron Healthcare Solutions, Inc. | 20 | $587 |
| E.r. Squibb & Sons, L.L.C. | 20 | $432 |
| Sun Pharmaceutical Industries Inc. | 19 | $350 |
| Lilly USA, LLC | 13 | $248 |
| UCB, Inc. | 12 | $244 |
| Pfizer | 13 | $236 |
| LEO Pharma Inc. | 9 | $203 |
| Johnson & Johnson | 9 | $170 |
| Mayne Pharma Commercial LLC | 9 | $117 |
| Dermavant Sciences, Inc. | 6 | $111 |
| Organogenesis Inc. | 2 | $64 |
| Amgen | 3 | $64 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $54 |
| Biofrontera Inc. | 2 | $43 |
| Botanix SB Inc | 2 | $40 |
| Almirall LLC | 2 | $33 |
| Organon | 2 | $32 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| EPI Health, LLC | 1 | $19 |
| LNHC, Inc | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Kerecis Limited | 1 | $16 |
| EMD Serono, Inc. | 1 | $15 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$57,817 in reported general payments places this provider in the 95th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 85 | $1,189 |
| ValacyclovirValacyclovir Hcl | 34 | $662 |
| Clobetasol Propionate | 24 | $567 |
| Ketoconazole | 29 | $490 |
| Mupirocin | 41 | $229 |
| Triamcinolone Acetonide | 20 | $129 |
| Cephalexin | 19 | $50 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Atlanta
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$711K
- Jamie WeismanAtlanta$620K
- Mack RachalAtlanta$260K
- Sumayah TaliaferroAtlanta$104K
- Sarah ChisolmAtlanta$59K
- Lauren OrensteinAtlanta$52K
- Chelsie RogersAtlanta$43K
- Ron FeldmanAtlanta$29K
- Christine LawAtlanta$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.